Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Aktis Oncology(AKTS) the Revenue is 3.384 M (--%), Beat estimate;the EBIT is -28.9 M (--%), Miss estimate;the EPS is -0.44 (--%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.00B--
0.00B--
+0.00B--%
EBITMiss expectations
-0.03B--
-0.03B--
-0.00B--%
EPSExceed expectations
-0.44--
-0.4461--
+0.0061--%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf